Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher L Corless

Showing results (171-180 of 208) with videos related to

Pageof 21
Sort By:
JCO Precision Oncology|October 26, 2019
Molecular Testing in Patients With Castration-Resistant Prostate Cancer and Its Impact on Clinical Decision MakingDerrick L Tao, Shawna Bailey, Tomasz M Beer, et al.
Plos Biology|May 5, 2005
Determination of stromal signatures in breast carcinomaRobert B West, Dimitry S A Nuyten, Subbaya Subramanian, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 5, 2008
Clinicopathologic profile of gastrointestinal stromal tumors (GISTs) with primary KIT exon 13 or exon 17 mutations: a multicenter study on 54 casesJerzy Lasota, Christopher L Corless, Michael C Heinrich, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 14, 2021
Novel BRAF gene fusions and activating point mutations in spindle cell sarcomas with histologic overlap with infantile fibrosarcomaAlyssa J Penning, Alyaa Al-Ibraheemi, Michael Michal, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 13, 2015
SWOG S0809: A Phase II Intergroup Trial of Adjuvant Capecitabine and Gemcitabine Followed by Radiotherapy and Concurrent Capecitabine in Extrahepatic Cholangiocarcinoma and Gallbladder CarcinomaEdgar Ben-Josef, Katherine A Guthrie, Anthony B El-Khoueiry, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 29, 2008
Primary and secondary kinase genotypes correlate with the biological and clinical activity of sunitinib in imatinib-resistant gastrointestinal stromal tumorMichael C Heinrich, Robert G Maki, Christopher L Corless, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 8, 2010
Phase III study comparing gemcitabine plus cetuximab versus gemcitabine in patients with advanced pancreatic adenocarcinoma: Southwest Oncology Group-directed intergroup trial S0205Philip A Philip, Jacqueline Benedetti, Christopher L Corless, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 19, 2014
Pathologic and molecular features correlate with long-term outcome after adjuvant therapy of resected primary GI stromal tumor: the ACOSOG Z9001 trialChristopher L Corless, Karla V Ballman, Cristina R Antonescu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 29, 2008
Correlation of kinase genotype and clinical outcome in the North American Intergroup Phase III Trial of imatinib mesylate for treatment of advanced gastrointestinal stromal tumor: CALGB 150105 Study by Cancer and Leukemia Group B and Southwest Oncology GroupMichael C Heinrich, Kouros Owzar, Christopher L Corless, et al.
The Journal of Molecular Diagnostics : JMD|July 6, 2011
Multiplex mutation screening by mass spectrometry evaluation of 820 cases from a personalized cancer medicine registryCarol Beadling, Michael C Heinrich, Andrea Warrick, et al.
Pageof 21

Showing results (171-180 of 208) with videos related to

Sort By:
Pageof 21
JCO Precision Oncology|October 26, 2019
Molecular Testing in Patients With Castration-Resistant Prostate Cancer and Its Impact on Clinical Decision MakingDerrick L Tao, Shawna Bailey, Tomasz M Beer, et al.
Plos Biology|May 5, 2005
Determination of stromal signatures in breast carcinomaRobert B West, Dimitry S A Nuyten, Subbaya Subramanian, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 5, 2008
Clinicopathologic profile of gastrointestinal stromal tumors (GISTs) with primary KIT exon 13 or exon 17 mutations: a multicenter study on 54 casesJerzy Lasota, Christopher L Corless, Michael C Heinrich, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 14, 2021
Novel BRAF gene fusions and activating point mutations in spindle cell sarcomas with histologic overlap with infantile fibrosarcomaAlyssa J Penning, Alyaa Al-Ibraheemi, Michael Michal, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 13, 2015
SWOG S0809: A Phase II Intergroup Trial of Adjuvant Capecitabine and Gemcitabine Followed by Radiotherapy and Concurrent Capecitabine in Extrahepatic Cholangiocarcinoma and Gallbladder CarcinomaEdgar Ben-Josef, Katherine A Guthrie, Anthony B El-Khoueiry, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 29, 2008
Primary and secondary kinase genotypes correlate with the biological and clinical activity of sunitinib in imatinib-resistant gastrointestinal stromal tumorMichael C Heinrich, Robert G Maki, Christopher L Corless, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 8, 2010
Phase III study comparing gemcitabine plus cetuximab versus gemcitabine in patients with advanced pancreatic adenocarcinoma: Southwest Oncology Group-directed intergroup trial S0205Philip A Philip, Jacqueline Benedetti, Christopher L Corless, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 19, 2014
Pathologic and molecular features correlate with long-term outcome after adjuvant therapy of resected primary GI stromal tumor: the ACOSOG Z9001 trialChristopher L Corless, Karla V Ballman, Cristina R Antonescu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 29, 2008
Correlation of kinase genotype and clinical outcome in the North American Intergroup Phase III Trial of imatinib mesylate for treatment of advanced gastrointestinal stromal tumor: CALGB 150105 Study by Cancer and Leukemia Group B and Southwest Oncology GroupMichael C Heinrich, Kouros Owzar, Christopher L Corless, et al.
The Journal of Molecular Diagnostics : JMD|July 6, 2011
Multiplex mutation screening by mass spectrometry evaluation of 820 cases from a personalized cancer medicine registryCarol Beadling, Michael C Heinrich, Andrea Warrick, et al.
Pageof 21